Type 2 diabetes remission 2 years post Roux-en-Y gastric bypass and sleeve gastrectomy: the role of the weight loss and comparison of DiaRem and DiaBetter scores

Diabetic Medicine

Volumn 35, Issue 3, 2018, Pages 360-367

  Pucci, A ^a,b   Tymoszuk, U ^c   Cheung, W H ^a,b   Makaronidis, J M ^a,b   Scholes, S ^a,c   Tharakan, G ^d   Elkalaawy, M ^b,e   Guimaraes, M ^f   Nora, M ^f   Hashemi, M ^b   Jenkinson, A ^b   Adamo, M ^b   Monteiro, M P ^f,g   Finer, N ^a,b   Batterham, R L ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c Department of Epidemiology & Public Health ^*  (United Kingdom)

^d IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^e ALEXANDRIA UNIVERSITY   (Egypt)

^f Centro Hospitalar de Entre O Douro e Vouga   (Portugal)

^g UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; HEMOGLOBIN A1C; INSULIN; METFORMIN; SODIUM GLUCOSE COTRANSPORTER 2 INHIBITOR; SULFONYLUREA; GLYCOSYLATED HEMOGLOBIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT LOSS; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETTER SCORE; DIAREM SCORE; DISEASE ASSESSMENT; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOME ASSESSMENT; RECEIVER OPERATING CHARACTERISTIC; REMISSION; RETROSPECTIVE STUDY; ROUX-EN-Y GASTRIC BYPASS; SLEEVE GASTRECTOMY; THERAPY EFFECT; BARIATRIC SURGERY; BLOOD; GASTRECTOMY; GASTRIC BYPASS SURGERY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROBABILITY; PROCEDURES; TREATMENT OUTCOME;

BARIATRIC SURGERY; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRECTOMY; GASTRIC BYPASS; GLYCATED HEMOGLOBIN A; HUMANS; MALE; MIDDLE AGED; PROBABILITY; REMISSION INDUCTION; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 85034567342     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.13532     Document Type: Article

References (24)

1. Angrisani L, Santonicola A, Iovino P, Formisano G, Buchwald H, Scopinaro N. Bariatric surgery worldwide 2013. Obes Surg 2015; 25: 1822–1832.
2. Schauer PR, Mingrone G, Ikramuddin S, Wolfe B. Clinical outcomes of metabolic surgery: efficacy of glycemic control, weight loss, and remission of diabetes. Diabetes Care 2016; 39: 902–911.
3. Adams TD, Arterburn DE, Nathan DM, Eckel RH. Clinical outcomes of metabolic surgery: microvascular and macrovascular complications. Diabetes Care 2016; 39: 912–923.
4. Manning S, Pucci A, Carter NC, Elkalaawy M, Querci G, Magno S et al. Early postoperative weight loss predicts maximal weight loss after sleeve gastrectomy and Roux-en-Y gastric bypass. Surg Endosc 2015; 29: 1484–1491.
5. Yousseif A, Emmanuel J, Karra E, Millet Q, Elkalaawy M, Jenkinson AD et al. Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans. Obes Surg 2014; 24: 241–252.
6. Keidar A, Hershkop KJ, Marko L, Schweiger C, Hecht L, Bartov N et al. Roux-en-Y gastric bypass vs sleeve gastrectomy for obese patients with type 2 diabetes: a randomised trial. Diabetologia 2013; 56: 1914–1918.
7. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD et al. Bariatric surgery versus intensive medical therapy for diabetes – 3-year outcomes. N Engl J Med 2014; 370: 2002–2013.
8. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Nanni G et al. Bariatric–metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet 2015; 386: 964–973.
9. Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KG, Zimmet PZ et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by International Diabetes Organizations. Diabetes Care 2016; 39: 861–877.
10. Lee WJ, Hur KY, Lakadawala M, Kasama K, Wong SK, Chen SC et al. Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score. Surg Obes Relat Dis 2013; 9: 379–384.
11. Still CD, Wood GC, Benotti P, Petrick AT, Gabrielsen J, Strodel WE et al. Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort study. Lancet Diabetes Endocrinol 2014; 2: 38–45.
12. Tharakan G, Scott R, Szepietowski O, Miras AD, Blakemore AI, Purkayastha S et al. Limitations of the DiaRem Score in predicting remission of diabetes following Roux-en-Y gastric bypass (RYGB) in an ethnically diverse population from a single institution in the UK. Obes Surg 2017; 27: 782–786.
13. Manning S, Carter NC, Pucci A, Jones A, Elkalaawy M, Cheung WH et al. Age- and sex-specific effects on weight loss outcomes in a comparison of sleeve gastrectomy and Roux-en-Y gastric bypass: a retrospective cohort study. BMC Obes 2014; 1: 12.
14. Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med 2015; 162: 55–63.
15. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837–845.
16. National Institute for Health and Care Excellence (NICE). Obesity Identification Assessment and Management. Clinical guideline 189. Available at https://www.nice.org.uk/guidance/cg189/chapter/1-Recommendations#bariatric-surgery-for-people-with-recent-onset-type-2-diabetes Last accessed 21 November 2016.
17. Ma RC, Chan JC. Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Ann NY Acad Sci 2013; 1281: 64–91.
18. Mayer-Davis EJ, Lawrence JM, Dabelea D, Divers J, Isom S, Dolan L et al. Incidence trends of Type 1 and Type 2 diabetes among youths, 2002–2012. N Engl J Med 2017; 376: 1419–1429.
19. Zhang C, Yuan Y, Qiu C, Zhang W. A meta-analysis of 2-year effect after surgery: laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for morbid obesity and diabetes mellitus. Obes Surg 2014; 24: 1528–1535.
20. Peterli R, Borbely Y, Kern B, Gass M, Peters T, Thurnheer M et al. Early results of the Swiss Multicentre Bypass or Sleeve Study (SM-BOSS): a prospective randomized trial comparing laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. Ann Surg 2013; 258: 690–694; discussion 695.
21. Edelman S, Ng-Mak DS, Fusco M, Ashton D, Okerson T, Liu Q et al. Control of type 2 diabetes after 1 year of laparoscopic adjustable gastric banding in the helping evaluate reduction in obesity (HERO) study. Diabetes Obes Metab 2014; 16: 1009–1015.
22. Steven S, Carey PE, Small PK, Taylor R. Reversal of Type 2 diabetes after bariatric surgery is determined by the degree of achieved weight loss in both short- and long-duration diabetes. Diabet Med 2015; 32: 47–53.
23. Sjoholm K, Sjostrom E, Carlsson LM, Peltonen M. Weight change-adjusted effects of gastric bypass surgery on glucose metabolism: two- and 10-year results from the Swedish Obese Subjects (SOS) Study. Diabetes Care 2016; 39: 625–631.
24. Jassil FC, Manning S, Lewis N, Steinmo S, Kingett H, Lough F et al. Feasibility and impact of a combined supervised exercise and nutritional–behavioral intervention following bariatric surgery: a pilot study. J Obes 2015; 2015: 693829.